13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF (ALFSG-MBT)
13C-Methacetin Breath Test for the Prediction of Outcome in in Acute Liver Injury or Acute Liver Failure
Sponsor: Medical University of South Carolina
A PHASE2/PHASE3 clinical study on Acute Liver Failure, this trial is completed. The trial is conducted by Medical University of South Carolina and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2021 — Feb 2023 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 8 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jun 2020 — Aug 2020 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Apr 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Nov 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Nov 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of South Carolina
- Meridian Bioscience, Inc.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Michigan
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .